The detailed information for PTAB case with proceeding number IPR2023-00512 filed by Apotex Inc. et al. against CELGENE CORPORATION et al. on Feb 10, 2023. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.
| Document Name | Filing Date | Category | Filing Party |
|---|---|---|---|
Alert me when new update on this case | |||
Termination Decision: Post-DI Settlement | Jan 5, 2024 | PAPER | BOARD |
Joint Motion to Terminate Proceeding | Jan 4, 2024 | PAPER | PETITIONER |
Joint Motion to Keep Settlement Confidential | Jan 4, 2024 | PAPER | PETITIONER |
Petitioner Exhibit 1060 Filed Under Seal | Jan 4, 2024 | EXHIBIT | PETITIONER |
Petitioner's Second Updated Mandatory Disclosures | Dec 14, 2023 | PAPER | PETITIONER |
Notice of Deposition of Cory Berkland | Nov 15, 2023 | PAPER | PETITIONER |
Notice of Deposition of George Grass | Nov 15, 2023 | PAPER | PETITIONER |
Notice of Deposition of Jeffrey Etter | Nov 15, 2023 | PAPER | PETITIONER |
Notice of Deposition of William G. Blum | Nov 15, 2023 | PAPER | PETITIONER |
Patent Owner's Updated Mandatory Notices | Nov 10, 2023 | PAPER | PATENT OWNER |
Order: Pro Hac Vice | Nov 7, 2023 | PAPER | BOARD |
Unopposed Motion for Pro Hac Vice Wigmore | Nov 2, 2023 | PAPER | PATENT OWNER |
Wigmore PHV Declaration | Nov 2, 2023 | EXHIBIT | PATENT OWNER |
Petitioner's First Updated Mandatory Disclosures | Oct 30, 2023 | PAPER | PETITIONER |
Passamaneck PHV Motion | Oct 25, 2023 | PAPER | PATENT OWNER |
Passamaneck PHV Declaration | Oct 25, 2023 | EXHIBIT | PATENT OWNER |
Danford PHV Motion | Oct 25, 2023 | PAPER | PATENT OWNER |
Danford PHV Declaration | Oct 25, 2023 | EXHIBIT | PATENT OWNER |
Petitioner's Second Set of Objections to Evidence | Oct 19, 2023 | PAPER | PETITIONER |
Pawar | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Batchelor Tr. | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Buckton Tr. | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
FDA Approves Onureg | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Canadian Product 200mg Onureg Product Information | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Canadian Product 300mg Onureg Product Information | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Canadian Product Monograph Onureg | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
European Commission Decision 17.6.21 | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
FASTtrack | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Onureg Label | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Gibson Supplemental | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Altman | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Ansel | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Antonsson | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Aulton | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Bankhead | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Ben-Kasus | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Carter | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Choi | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Cogle | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Covey | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Craig | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Curtiss | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
DeSimone | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Dressman | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Dunbar | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Ellisson | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
FDA Approves Oral Azacitidine | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Frisch | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Futterman | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Garcia-Manero | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Goldin | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Griffiths | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Gronbaek | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Hrodek | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Kantarjian | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Karon | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Kipp | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Kornblith | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Lammers | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Lin 2022 | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Liu | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Lomen | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Lowenberg | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Ma | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
McCredie | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Neil | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Odenike | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Oral CC-486 | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Perl | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Porta | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Preisler | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Recher | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Reville | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Shnider | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Slater | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Sochacka-Cwikla | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Sorm | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Sorrentino | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Southall | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Steensma | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Surbone | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Toutain | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
60/824,320 | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
US2008/0057086 | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Vigil | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Vogler I | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Vogler II | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
VonHoff | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Wei | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Weill Cornell | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Zielinski | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Ziemba | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Exemestane | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Anastrozole | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Letrozole | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Blum | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Dacogen | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Mitoxantrone | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Finkel | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Martinez | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
European Medicines Report | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Hirayama | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Dean | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Remington 2005 II | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Gilbaldi | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Huls | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Cytarabine | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Lieberman Vol. 1 | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Remington 1990 | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
First Expert Declaration of James L. Mullins, Ph.D. | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Second Expert Declaration of James L. Mullins, Ph.D. | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Berkland Decl. | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Grass Decl | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Blum Decl | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Etter Decl | Oct 12, 2023 | EXHIBIT | PATENT OWNER |
Patent Owner's Response | Oct 12, 2023 | PAPER | PATENT OWNER |
Patent Owner's Second Updated Mandatory Notices | Oct 4, 2023 | PAPER | PATENT OWNER |
Buckton Deposition Notice | Sep 11, 2023 | PAPER | PATENT OWNER |
Batchelor Deposition Notice | Sep 11, 2023 | PAPER | PATENT OWNER |
Patent Owner's Updated Mandatory Notice | Sep 6, 2023 | PAPER | PATENT OWNER |
Patent Owner's Objections to Evidence | Aug 3, 2023 | PAPER | PATENT OWNER |
Petitioner's Objections to Patent Owner's Evidence Pursuant to 37 C.F.R. § 42.64 | Aug 3, 2023 | PAPER | PETITIONER |
E-mail re party name | Jul 21, 2023 | EXHIBIT | BOARD |
Institution Decision: Granting Instituting Inter Partes Review 35 U.S.C. sec. 314 | Jul 20, 2023 | PAPER | BOARD |
Order: SCHEDULING ORDER | Jul 20, 2023 | PAPER | BOARD |
PATENT OWNER’S PRELIMINARY RESPONSE | May 15, 2023 | PAPER | PATENT OWNER |
Berkland Declaration | May 15, 2023 | EXHIBIT | PATENT OWNER |
FDA approves Onureg | May 15, 2023 | EXHIBIT | PATENT OWNER |
Aparicio | May 15, 2023 | EXHIBIT | PATENT OWNER |
Beisler | May 15, 2023 | EXHIBIT | PATENT OWNER |
200mg Onureg Product Information | May 15, 2023 | EXHIBIT | PATENT OWNER |
300mg Onureg Product Information | May 15, 2023 | EXHIBIT | PATENT OWNER |
Canadian Product Monograph Onureg | May 15, 2023 | EXHIBIT | PATENT OWNER |
Chabner | May 15, 2023 | EXHIBIT | PATENT OWNER |
Chen | May 15, 2023 | EXHIBIT | PATENT OWNER |
Cheung | May 15, 2023 | EXHIBIT | PATENT OWNER |
Čihák | May 15, 2023 | EXHIBIT | PATENT OWNER |
European Commission Decision | May 15, 2023 | EXHIBIT | PATENT OWNER |
Connors | May 15, 2023 | EXHIBIT | PATENT OWNER |
Evans | May 15, 2023 | EXHIBIT | PATENT OWNER |
FASTtrack | May 15, 2023 | EXHIBIT | PATENT OWNER |
Gaubert | May 15, 2023 | EXHIBIT | PATENT OWNER |
Kaminskas | May 15, 2023 | EXHIBIT | PATENT OWNER |
Kissinger | May 15, 2023 | EXHIBIT | PATENT OWNER |
Lieberman | May 15, 2023 | EXHIBIT | PATENT OWNER |
Lin | May 15, 2023 | EXHIBIT | PATENT OWNER |
Mund | May 15, 2023 | EXHIBIT | PATENT OWNER |
National Cancer Institute | May 15, 2023 | EXHIBIT | PATENT OWNER |
Notari | May 15, 2023 | EXHIBIT | PATENT OWNER |
Onureg Label | May 15, 2023 | EXHIBIT | PATENT OWNER |
WO2009/139888 | May 15, 2023 | EXHIBIT | PATENT OWNER |
Piťhová | May 15, 2023 | EXHIBIT | PATENT OWNER |
Remington 2005 | May 15, 2023 | EXHIBIT | PATENT OWNER |
Stresemann | May 15, 2023 | EXHIBIT | PATENT OWNER |
Ionescu-065 | May 15, 2023 | EXHIBIT | PATENT OWNER |
Weiss | May 15, 2023 | EXHIBIT | PATENT OWNER |
Celgene v. Accord | May 15, 2023 | EXHIBIT | PATENT OWNER |
Zeldis | May 15, 2023 | EXHIBIT | PATENT OWNER |
Glover | May 15, 2023 | EXHIBIT | PATENT OWNER |
Ionescu-855 | May 15, 2023 | EXHIBIT | PATENT OWNER |
Ionescu-518 | May 15, 2023 | EXHIBIT | PATENT OWNER |
Ionescu-199 | May 15, 2023 | EXHIBIT | PATENT OWNER |
Ionescu-189 | May 15, 2023 | EXHIBIT | PATENT OWNER |
Ionescu-253 | May 15, 2023 | EXHIBIT | PATENT OWNER |
Ward | May 15, 2023 | EXHIBIT | PATENT OWNER |
WO2008/028193 | May 15, 2023 | EXHIBIT | PATENT OWNER |
Gibson Supplemental | May 15, 2023 | EXHIBIT | PATENT OWNER |
Lieberman Vol. 2 | May 15, 2023 | EXHIBIT | PATENT OWNER |
WO2004/082618 | May 15, 2023 | EXHIBIT | PATENT OWNER |
Celgene v. Accord | May 15, 2023 | EXHIBIT | PATENT OWNER |
Savage | May 15, 2023 | EXHIBIT | PATENT OWNER |
Notice : Power of Attorney | Mar 1, 2023 | PAPER | PATENT OWNER |
Patent Owner's Mandatory Notice | Mar 1, 2023 | PAPER | PATENT OWNER |
Notice: Notice filing date accorded | Feb 15, 2023 | PAPER | BOARD |
Petition : as filed | Feb 10, 2023 | PAPER | PETITIONER |
Notice : Petitioner Power of Attorney | Feb 10, 2023 | PAPER | PETITIONER |
EX 1001 USP 8,846,628 (Etter) | Feb 10, 2023 | EXHIBIT | PETITIONER |
EX 1002 Buckton Declaration | Feb 10, 2023 | EXHIBIT | PETITIONER |
EX 1003 Batchelor Declaration | Feb 10, 2023 | EXHIBIT | PETITIONER |
EX 1004 WO 2004-082619 (Ionescu) | Feb 10, 2023 | EXHIBIT | PETITIONER |
EX 1005 WO 2004-103358 (Atadja) | Feb 10, 2023 | EXHIBIT | PETITIONER |
EX 1006 Gibson | Feb 10, 2023 | EXHIBIT | PETITIONER |
EX 1007 Vidaza Label 2004 | Feb 10, 2023 | EXHIBIT | PETITIONER |
EX 1008 Vidaza Label 2007 | Feb 10, 2023 | EXHIBIT | PETITIONER |
EX 1009 WO 2004-082822A2 (Ionescu '822) | Feb 10, 2023 | EXHIBIT | PETITIONER |
EX 1010 Pharmion-PR | Feb 10, 2023 | EXHIBIT | PETITIONER |
EX 1011 Pharmion-PR II | Feb 10, 2023 | EXHIBIT | PETITIONER |
EX 1012 Pharmion 10-K | Feb 10, 2023 | EXHIBIT | PETITIONER |
EX 1013 Rowe (Handbook) | Feb 10, 2023 | EXHIBIT | PETITIONER |
EX 1014 Chan | Feb 10, 2023 | EXHIBIT | PETITIONER |
EX 1015 Kelley | Feb 10, 2023 | EXHIBIT | PETITIONER |
EX 1016 Vorbruggen | Feb 10, 2023 | EXHIBIT | PETITIONER |
EX 1017 Marcucci | Feb 10, 2023 | EXHIBIT | PETITIONER |
EX 1018 Thomson | Feb 10, 2023 | EXHIBIT | PETITIONER |
EX 1019 USP Publ 2006-0074046A1 (Redkar) | Feb 10, 2023 | EXHIBIT | PETITIONER |
EX 1020 Dintaman | Feb 10, 2023 | EXHIBIT | PETITIONER |
EX 1021 USP Publ 2004-0162263A1 (Sands) | Feb 10, 2023 | EXHIBIT | PETITIONER |
EX 1022 628 File History, Part 1 of 3 | Feb 10, 2023 | EXHIBIT | PETITIONER |
EX 1022 628 File History, Part 2 of 3 | Feb 10, 2023 | EXHIBIT | PETITIONER |
EX 1022 628 File History, Part 3 of 3 | Feb 10, 2023 | EXHIBIT | PETITIONER |
EX 1023 USP 3,350,388A (Sorm) | Feb 10, 2023 | EXHIBIT | PETITIONER |
EX 1024 Piskala (1964) | Feb 10, 2023 | EXHIBIT | PETITIONER |
EX 1025 GB1227691 | Feb 10, 2023 | EXHIBIT | PETITIONER |
EX 1026 USP Publ 2008-0057086A1 (Etter) | Feb 10, 2023 | EXHIBIT | PETITIONER |
EX 1027 GastroPlus v5.2 Manual | Feb 10, 2023 | EXHIBIT | PETITIONER |
EX 1029 Modern Pharmaceutics | Feb 10, 2023 | EXHIBIT | PETITIONER |
EX 1030 Remington | Feb 10, 2023 | EXHIBIT | PETITIONER |
EX 1031 Dover | Feb 10, 2023 | EXHIBIT | PETITIONER |
EX 1032 Hardy | Feb 10, 2023 | EXHIBIT | PETITIONER |
EX 1033 Ewe | Feb 10, 2023 | EXHIBIT | PETITIONER |
EX 1034 Stoltz | Feb 10, 2023 | EXHIBIT | PETITIONER |
EX 1036 609 provisional | Feb 10, 2023 | EXHIBIT | PETITIONER |
EX 1037 Schwarz | Feb 10, 2023 | EXHIBIT | PETITIONER |
EX 1038 Amidon | Feb 10, 2023 | EXHIBIT | PETITIONER |
EX 1039 Buck | Feb 10, 2023 | EXHIBIT | PETITIONER |
EX 1040 Dannenfelser | Feb 10, 2023 | EXHIBIT | PETITIONER |
EX 1041 GP5.2 PR | Feb 10, 2023 | EXHIBIT | PETITIONER |
EX 1042 IARC | Feb 10, 2023 | EXHIBIT | PETITIONER |
EX 1043 Israili | Feb 10, 2023 | EXHIBIT | PETITIONER |
EX 1044 Kuentz | Feb 10, 2023 | EXHIBIT | PETITIONER |
EX 1045 Li | Feb 10, 2023 | EXHIBIT | PETITIONER |
EX 1046 Obach | Feb 10, 2023 | EXHIBIT | PETITIONER |
EX 1047 Parrott | Feb 10, 2023 | EXHIBIT | PETITIONER |
EX 1048 Simulations Plus (SLP 10-OSB) | Feb 10, 2023 | EXHIBIT | PETITIONER |
EX 1049 FDA Guidance for Industry | Feb 10, 2023 | EXHIBIT | PETITIONER |
EX 1050 '875 provisional | Feb 10, 2023 | EXHIBIT | PETITIONER |
EX 1051 ʼ145 provisional | Feb 10, 2023 | EXHIBIT | PETITIONER |
EX 1052 Conformer3D_CID_9444 (1) (sdf) | Feb 10, 2023 | EXHIBIT | PETITIONER |
EX 1053 Azacitidine ADMET (txt) | Feb 10, 2023 | EXHIBIT | PETITIONER |
EX 1054 Azacitidine 200 mg (cdd) | Feb 10, 2023 | EXHIBIT | PETITIONER |
EX 1055 Azacitidine 200 mg (ipd) | Feb 10, 2023 | EXHIBIT | PETITIONER |
EX 1056 Azacitidine 200mg All Data (txt) | Feb 10, 2023 | EXHIBIT | PETITIONER |
EX 1057 Azacitidine 400 mg (cdd) | Feb 10, 2023 | EXHIBIT | PETITIONER |
EX 1058 Azacitidine 400 mg (ipd) | Feb 10, 2023 | EXHIBIT | PETITIONER |
EX 1059 Azacitidine 400mg All Data (txt) | Feb 10, 2023 | EXHIBIT | PETITIONER |